Treatment Arm
Visit number vs Total number of central apneas with no oxygen desaturation threshold used during estimated sleep in non-supine position from type III home sleep apnea test
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Baseline | 316 | 1.7 | ± 4.5 | 0.0 | 0.0 | 35.0 | 2 | 318 |
| Follow-up | 275 | 0.9 | ± 2.5 | 0.0 | 0.0 | 31.0 | 26 | 301 |
Treatment Arm vs Total number of central apneas with no oxygen desaturation threshold used during estimated sleep in non-supine position from type III home sleep apnea test
Baseline
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 316 | 1.7 | ± 4.5 | 0.0 | 0.0 | 35.0 | 2 | 318 |
| Healthy Lifestyles and Sleep Education - control arm (HLSE) | 106 | 1.7 | ± 4.4 | 0.0 | 0.0 | 28.0 | - | 106 |
| Healthy Lifestyles and Sleep Education + (supplemental nocturnal) Oxygen - oxygen arm (HLSE-O) | 105 | 1.6 | ± 4.2 | 0.0 | 0.0 | 35.0 | 1 | 106 |
| Healthy Lifestyles and Sleep Education + Positive airway pressure treatment - CPAP arm (HLSE-P) | 105 | 1.7 | ± 5.0 | 0.0 | 0.0 | 34.0 | 1 | 106 |
Treatment Arm vs Total number of central apneas with no oxygen desaturation threshold used during estimated sleep in non-supine position from type III home sleep apnea test
Follow-up
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 275 | 0.9 | ± 2.5 | 0.0 | 0.0 | 31.0 | 26 | 301 |
| Healthy Lifestyles and Sleep Education - control arm (HLSE) | 94 | 1.0 | ± 1.9 | 0.0 | 0.0 | 10.0 | 6 | 100 |
| Healthy Lifestyles and Sleep Education + (supplemental nocturnal) Oxygen - oxygen arm (HLSE-O) | 95 | 0.9 | ± 3.3 | 0.0 | 0.0 | 31.0 | 6 | 101 |
| Healthy Lifestyles and Sleep Education + Positive airway pressure treatment - CPAP arm (HLSE-P) | 86 | 0.7 | ± 2.0 | 0.0 | 0.0 | 17.0 | 14 | 100 |
Age category vs Total number of central apneas with no oxygen desaturation threshold used during estimated sleep in non-supine position from type III home sleep apnea test
Baseline
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 316 | 1.7 | ± 4.5 | 0.0 | 0.0 | 35.0 | 2 | 318 |
| 45-54 years | 52 | 1.3 | ± 3.7 | 0.0 | 0.0 | 20.0 | 1 | 53 |
| 55-64 years | 139 | 1.5 | ± 4.5 | 0.0 | 0.0 | 35.0 | - | 139 |
| 65 years or older | 125 | 2.0 | ± 4.9 | 0.0 | 0.0 | 34.0 | 1 | 126 |
Age category vs Total number of central apneas with no oxygen desaturation threshold used during estimated sleep in non-supine position from type III home sleep apnea test
Follow-up
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 275 | 0.9 | ± 2.5 | 0.0 | 0.0 | 31.0 | 25 | 300 |
| 45-54 years | 42 | 1.0 | ± 1.8 | 0.0 | 0.0 | 9.0 | 7 | 49 |
| 55-64 years | 117 | 0.9 | ± 3.0 | 0.0 | 0.0 | 31.0 | 10 | 127 |
| 65 years or older | 116 | 0.8 | ± 2.1 | 0.0 | 0.0 | 17.0 | 8 | 124 |
Gender of the participant vs Total number of central apneas with no oxygen desaturation threshold used during estimated sleep in non-supine position from type III home sleep apnea test
Baseline
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 316 | 1.7 | ± 4.5 | 0.0 | 0.0 | 35.0 | 2 | 318 |
| Female | 84 | 1.0 | ± 2.9 | 0.0 | 0.0 | 22.0 | - | 84 |
| Male | 232 | 1.9 | ± 5.0 | 0.0 | 0.0 | 35.0 | 2 | 234 |
Gender of the participant vs Total number of central apneas with no oxygen desaturation threshold used during estimated sleep in non-supine position from type III home sleep apnea test
Follow-up
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 275 | 0.9 | ± 2.5 | 0.0 | 0.0 | 31.0 | 26 | 301 |
| Female | 73 | 0.5 | ± 1.2 | 0.0 | 0.0 | 7.0 | 6 | 79 |
| Male | 202 | 1.0 | ± 2.8 | 0.0 | 0.0 | 31.0 | 20 | 222 |
Race of the participant vs Total number of central apneas with no oxygen desaturation threshold used during estimated sleep in non-supine position from type III home sleep apnea test
Baseline
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 315 | 1.7 | ± 4.6 | 0.0 | 0.0 | 35.0 | 2 | 317 |
| White | 255 | 1.7 | ± 4.5 | 0.0 | 0.0 | 34.0 | 1 | 256 |
| American Indian or Alaskan Native | 2 | 0.0 | ± 0.0 | 0.0 | 0.0 | 0.0 | - | 2 |
| Black or African American | 42 | 1.7 | ± 5.6 | 0.0 | 0.0 | 35.0 | 1 | 43 |
| Asian | 6 | 0.7 | ± 1.2 | 0.0 | 0.0 | 3.0 | - | 6 |
| Native Hawaiian or other Pacific islander | 1 | 3.0 | - | 3.0 | 3.0 | 3.0 | - | 1 |
| Other | 4 | 0.0 | ± 0.0 | 0.0 | 0.0 | 0.0 | - | 4 |
| Multiple | 5 | 0.6 | ± 0.5 | 1.0 | 0.0 | 1.0 | - | 5 |
Race of the participant vs Total number of central apneas with no oxygen desaturation threshold used during estimated sleep in non-supine position from type III home sleep apnea test
Follow-up
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 274 | 0.9 | ± 2.5 | 0.0 | 0.0 | 31.0 | 25 | 299 |
| White | 222 | 1.0 | ± 2.7 | 0.0 | 0.0 | 31.0 | 19 | 241 |
| American Indian or Alaskan Native | 2 | 0.0 | ± 0.0 | 0.0 | 0.0 | 0.0 | - | 2 |
| Black or African American | 35 | 0.4 | ± 0.7 | 0.0 | 0.0 | 2.0 | 6 | 41 |
| Asian | 6 | 1.5 | ± 1.6 | 1.0 | 0.0 | 4.0 | - | 6 |
| Native Hawaiian or other Pacific islander | 1 | 0.0 | - | 0.0 | 0.0 | 0.0 | - | 1 |
| Other | 3 | 0.3 | ± 0.6 | 0.0 | 0.0 | 1.0 | - | 3 |
| Multiple | 5 | 0.8 | ± 1.8 | 0.0 | 0.0 | 4.0 | - | 5 |